Travis Young BS, PhD

Travis Young received a Ph.D. in chemical biology from The Scripps Research Institute and a BS in biochemistry from Boston College. He is currently the Director of Protein Sciences at The California Institute for Biomedical Research. Prior to joining Calibr, he was a postdoc at Harvard Medical School in the department of Biological Chemistry and Molecular Pharmacology where he worked with Dr. Christopher T Walsh.

At Caliber he serves as the lead investigator on bispecific antibody and CAR-T cell programs and heads a group in antibody engineering and expression. The group’s research focuses on the development of novel antibody-based therapeutics in the bispecific antibody and CAR-T cell fields. This work has been awarded support from multiple funding bodies including the Wellcome Trust, NIH (NCI), Department of Defense, Mesothelioma Research Foundation, and the American Cancer Society. His team has developed multiple preclinical assets that will be first-in-class molecules expected to enter the clinic over the next 2 years.